1 Matsuzawa Y (2010) Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad Ser B Phys Biol Sci 86, 131–141.
2 Wu CH, Lu FH, Chang CS, et al. (2003) Relationship among habitual tea consumption, percent body fat, and body fat distribution. Obes Res 11, 1088–1095.
3 Wolfram S, Wang Y & Thielecke F (2006) Anti-obesity effects of green tea: from bedside to bench. Mol Nutr Food Res 50, 176–187.
4 Thielecke F & Boschmann M (2009) The potential role of green tea catechins in the prevention of the metabolic syndrome – a review. Phytochemistry 70, 11–24.
5 Roberfroid MB (2007) Inulin-type fructans: functional food ingredients. J Nutr 137, 2493S–2502S.
6 Delzenne NM, Daubioul C, Neyrinck A, et al. (2002) Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr 87, Suppl. 2, S255–S259.
7 Urias-Silvas JE, Cani PD, Delmee E, et al. (2008) Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp. Br J Nutr 99, 254–261.
8 Murase T, Nagasawa A, Suzuki J, et al. (2002) Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 26, 1459–1464.
9 Boschmann M & Thielecke F (2007) The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J Am Coll Nutr 26, 389S–395S.
10 Ikeda I, Hamamoto R, Uzu K, et al. (2005) Dietary gallate esters of tea catechins reduce deposition of visceral fat, hepatic triacylglycerol, and activities of hepatic enzymes related to fatty acid synthesis in rats. Biosci Biotechnol Biochem 69, 1049–1053.
11 Wolfram S, Raederstorff D, Wang Y, et al. (2005) TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metab 49, 54–63.
12 Diepvens K, Kovacs EM, Nijs IM, et al. (2005) Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females. Br J Nutr 94, 1026–1034.
13 Dulloo AG, Duret C, Rohrer D, et al. (1999) Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70, 1040–1045.
14 Choo JJ (2003) Green tea reduces body fat accretion caused by high-fat diet in rats through beta-adrenoceptor activation of thermogenesis in brown adipose tissue. J Nutr Biochem 14, 671–676.
15 Bose M, Lambert JD, Ju J, et al. (2008) The major green tea polyphenol, ( − )-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138, 1677–1683.
16 Nagao T, Komine Y, Soga S, et al. (2005) Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr 81, 122–129.
17 Matsuyama T, Tanaka Y, Kamimaki I, et al. (2008) Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring) 16, 1338–1348.
18 Nagao T, Hase T & Tokimitsu I (2007) A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 15, 1473–1483.
19 Reto M, Figueira ME, Filipe HM, et al. (2007) Chemical composition of green tea (Camellia sinensis) infusions commercialized in Portugal. Plant Foods Hum Nutr 62, 139–144.
20 Hursel R, Viechtbauer W & Westerterp-Plantenga MS (2009) The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond) 33, 956–961.
21 Westerterp-Plantenga MS, Lejeune MP & Kovacs EM (2005) Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 13, 1195–1204.
22 Imai K & Nakachi K (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310, 693–696.
23 Sasazuki S, Kodama H, Yoshimasu K, et al. (2000) Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 10, 401–408.
24 Yang YC, Lu FH, Wu JS, et al. (2004) The protective effect of habitual tea consumption on hypertension. Arch Intern Med 164, 1534–1540.